Feronia Inc. announced that Larry Seruma, currently a non-executive director, has been appointed as Executive Chairman. David White, a current non-executive director and Chairman of the Audit Committee, has resigned and, in replacement, Paul Wythe has been appointed as a non-executive director and Chairman of the Audit Committee. In accordance with the terms of the Support Agreement, CDC has agreed to suspend its existing rights to nominate directors to the Board during the restructuring period and, as a result, David Osborne and Andrew Brown have also resigned as directors. Kamal Pallan has been appointed to join the Board as a further non-executive director nominee of KKM. The appointments of Wythe and Pallan are subject to the approval of the TSX Venture Exchange.